Harmony Biosciences Holdings Inc (HRMY) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Harmony Biosciences Holdings inc   (NASDAQ: HRMY)


Harmony Biosciences Holdings Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Harmony Biosciences Holdings Inc 's ROA in the second quarter of 2026?
Harmony Biosciences Holdings inc achieved a return on average assets (ROA) of 14.15 % in its second quarter of 2026, which is below Harmony Biosciences Holdings Inc 's average return on assets, which stands at 16.8%.

ROA has improved compared to 11.99% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 68 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 464 to 493.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 23.92 % 20.49 % 56.87 % 62.26 % 63.07 %
Y / Y Net Income Change 89.64 % -28.69 % -54.55 % 10.35 % 243.16 %
Net Income (TTM) in million 181 146 159 186 181
Return On Assets (TTM) 14.15 % 11.99 % 13.67 % 17.76 % 19.46 %
HRMY's Total Ranking # 493 # 464 # 293 # 281 # 326
Total Assets (TTM) in million 1,373 1,272 1,272 1,208 1,108
Seq. Total Assets Change 7.96 % 0.02 % 5.25 % 9.04 % 4.97 %
Seq. Net Income Change 132.18 % 44.48 % -55.79 % 27.88 % -12.7 %

HRMY's 5 Years Annual ROA >> Back to HRMY Management Effectiveness >> Compare HRMY ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 31
Sector # 69
Overall # 382

Return On Assets Statistics
High Average Low
31.75 %
16.8 %
3.08 %
(Dec 31 2022)   (Sep 30 2021)





Financial Statements
Harmony Biosciences Holdings Inc 's Assets $ 1,373 million HRMY's Balance sheet
Harmony Biosciences Holdings Inc 's Income $ 75 million Quarterly HRMY's Income Statement
HRMY's Income by Division See HRMY's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 70.08 % -0.13 % 20.19 % 55.82 % 1.49 %
Total Assets in million 1,379 811 812 675 433
Y / Y Net Income Change 9.07 % 12.91 % -28.99 % 424.52 % -
Net Income in million 159 145 129 181 35
Annual Return On Assets 11.51 % 17.95 % 15.87 % 26.87 % 7.98 %

HRMY's 5 Years Annual ROA >> Back to HRMY Management Effectiveness >> Compare HRMY ROA to its Competitors



Comment on HRMY's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA deteriorated to 11.51 %, despite annual net income growth of 9.07 % to $158.69 million, from $145.49 million a year ago, as HRMY's assets increase to $1,378.76 million, by 9.07 %.


More Return On Assets Ratios
HRMY's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
HRMY's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for HRMY's Competitors
Subscribers only: Roa for Harmony Biosciences Holdings Inc 's Suppliers
Subscribers only: Return On Assets for HRMY's Customers

You may also want to know
HRMY's Roi HRMY's Inventory Turnover Ratio HRMY's Growth Rates HRMY's Dividend Comparisons
HRMY's Profitability Ratios HRMY's Asset Turnover Ratio HRMY's Dividend Growth
HRMY's Roe HRMY's Valuation Ratios HRMY's Financial Strength Ratios HRMY's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Liquidia Corporation  36.30 %
Ironwood Pharmaceuticals inc   34.34 %
Idexx Laboratories Inc  33.61 %
Tg Therapeutics Inc   33.59 %
Meiragtx Holdings Plc  29.37 %
Indivior Pharmaceuticals Inc   28.21 %
Qhslab Inc   27.12 %
Adma Biologics Inc   26.58 %
Mettler toledo International Inc   24.86 %
Medpace Holdings Inc   24.84 %
Caredx Inc   24.81 %
Acadia Pharmaceuticals Inc   24.38 %
Eli Lilly And Company  21.97 %
Innoviva Inc   21.64 %
Vaxart Inc   20.85 %
Zevra Therapeutics Inc   20.39 %
Iradimed Corporation  20.36 %
Protalix Biotherapeutics inc   20.09 %
Pro dex Inc   19.87 %
Electromed Inc   19.39 %
United Therapeutics Corporation  17.98 %
Resmed Inc   17.80 %
Krystal Biotech Inc   17.65 %
Chemed Corporation  17.52 %
Zoetis Inc   17.19 %
Vertex Pharmaceuticals Inc  16.88 %
Halozyme Therapeutics Inc   16.55 %
Alnylam Pharmaceuticals Inc   15.76 %
Intuitive Surgical Inc   15.63 %
Healthcare Services Group Inc   15.21 %

Date modified: 2026-09-26T07:38:37+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.